The United States’ largest airlines cannot pick and choose how its governments’ “open skies” agreements are enforced without consequences, Emirates airline President warned on Tuesday as he continues to fend off accusations of subsidies.
The three biggest US carriers — Delta, United and American — want their government to freeze Emirates, Etihad Airways, and Qatar Airways’ access to the country and open up consultations with their national governments over allegations of state subsidies.
“If you shutdown open skies, anti-trust immunity has to go because you are creating a competitive imbalance,” Tim Clark told reporters at the International Air Transport Association annual meet in Miami.
Open skies agreements, which the US has with the UAE and Qatar, allows airlines from the signatory countries to fly unrestricted between their home country and to the other signatory country.
In the US, domestic and their international partner airlines have received antitrust immunity, which allows them to coordinate on pricing and schedules, among other privileges.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan